AJANTA PHARMA
Back to Cashflow Statement
|
AJANTA PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-168 Cr | ₹-733 Cr | ₹-1,051 Cr | ₹-108 Cr | ₹-460 Cr |
What is the latest Cash Flow from Financing Activities ratio of AJANTA PHARMA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-168 Cr |
| Mar2025 | ₹-733 Cr |
| Mar2024 | ₹-1,051 Cr |
| Mar2023 | ₹-108 Cr |
| Mar2022 | ₹-460 Cr |
How is Cash Flow from Financing Activities of AJANTA PHARMA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-168 Cr | Negative | |
| Mar2025 | ₹-733 Cr | Negative | |
| Mar2024 | ₹-1,051 Cr | Negative | |
| Mar2023 | ₹-108 Cr | Negative | |
| Mar2022 | ₹-460 Cr | - | |
Compare Cash Flow from Financing Activities of peers of AJANTA PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AJANTA PHARMA | ₹42,675.8 Cr | -0.2% | 10.8% | 33.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,815.0 Cr | 0.5% | 6.2% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,678.0 Cr | 4.7% | 9% | 7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,323.0 Cr | -3.7% | 7.2% | 49.8% | Stock Analytics | |
| CIPLA | ₹114,585.0 Cr | -0.6% | 5% | -3.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,067.0 Cr | -1.9% | -4.6% | -2.8% | Stock Analytics | |
AJANTA PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AJANTA PHARMA | -0.2% |
10.8% |
33.2% |
| SENSEX | 0.8% |
1.8% |
-6.5% |
You may also like the below Video Courses